Infectious Diseases in Obstetrics and Gynecology American Journal of Obstetrics and Gynecology, vol. 160, no. 5, pp. 1117–1123, 1989. [19] E. Protonotariou, C. Chrelias, D. Kassanos, H. Kapsambeli, E. Trakakis, and A. Sarandakou, “Immune response parameters during labor and early neonatal life,” In Vivo, vol. 24, no. 1, pp. 117–124, 2010. [20] T. M. Lindstro¨m and P. R. Bennett, “The role of nuclear factor kappa B in human labour,” Reproduction, vol. 130, no. 5, pp. 569–581, 2005. [21] H. Yadi, S. Burke, Z. Madeja, M. Hemberger, A. Moﬀett, and F. Colucci, “Unique receptor repertoire in mouse uterine NK cells,” The Journal of Immunology, vol. 181, no. 9, pp. 6140– 6147, 2008. [22] S. S. Kalkunte, T. F. Mselle, W. E. Norris, C. R. Wira, C. L. Sentman, and S. Sharma, “Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface,” The Journal of Immunology, vol. 182, no. 7, pp. 4085–4092, 2009. [23] J. Hanna, D. Goldman-Wohl, Y. Hamani et al., “Decidual NK cells regulate key developmental processes at the human fetal- maternal interface,” Nature Medicine, vol. 12, no. 9, pp. 1065– 1074, 2006. [24] G. Barrientos, I. Tirado-Gonza´lez, B. F. Klapp et al., “The impact of dendritic cells on angiogenic responses at the fetal- maternal interface,” Journal of Reproductive Immunology, vol. 83, no. 1-2, pp. 85–94, 2009. [25] J. E. Thaxton and S. Sharma, “Interleukin-10: a multi- faceted agent of pregnancy,” American Journal of Reproductive Immunology, vol. 63, no. 6, pp. 482–491, 2010. [26] A. A. Ashkar, J. P. Di Santo, and B. A. Croy, “Interferon γ contributes to initiation of uterine vascular modiﬁcation, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy,” Journal of Experimental Medicine, vol. 192, no. 2, pp. 259–269, 2000. [27] S. J. Renaud and C. H. Graham, “The role of macrophages in utero-placental interactions during normal and pathological pregnancy,” Immunological Investigations, vol. 37, no. 5-6, pp. 535–564, 2008. [28] A. L. V. van Nieuwenhoven, M. J. Heineman, and M. M. Faas, “The immunology of successful pregnancy,” Human Reproduction Update, vol. 9, no. 4, pp. 347–357, 2003. [29] G. Soboll, T. M. Schaefer, and C. R. Wira, “Eﬀect of Toll-like receptor (TLR) agonists on TLR and microbicide expression in uterine and vaginal tissues of the mouse,” American Journal of Reproductive Immunology, vol. 55, no. 6, pp. 434–446, 2006. [30] Y. Kyaw, G. Hasegawa, H. Takatsuka et al., “Expression of macrophage colony-stimulating factor, scavenger receptors, and macrophage proliferation in the pregnant mouse uterus,” Archives of Histology and Cytology, vol. 61, no. 5, pp. 383–393, 1998. [31] R. Romero, M. Ceska, C. Avila, M. Mazor, E. Behnke, and I. Lindley, “Neutrophil attractant/activating peptide- 1/interleukin-8 in term and preterm parturition,” American Journal of Obstetrics and Gynecology, vol. 165, no. 4 I, pp. 813– 820, 1991. [32] S. M. Blois, G. Barrientos, M. G. Garcia et al., “Interaction between dendritic cells and natural killer cells during preg- nancy in mice,” Journal of Molecular Medicine, vol. 86, no. 7, pp. 837–852, 2008. [33] P. Bizargity and E. A. Bonney, “Dendritic cells: a family portrait at mid-gestation,” Immunology, vol. 126, no. 4, pp. 565–578, 2009. 7 [34] A. C. Zenclussen, K. Gerlof, M. L. Zenclussen et al., “Abnormal T-cell reactivity against paternal antigens in spon- taneous abortion: adoptive transfer of pregnancy-induced CD4+CD4+ T regulatory cells prevents fetal rejection in a murine abortion model,” American Journal of Pathology, vol. 166, no. 3, pp. 811–822, 2005. [35] P. Bizargity, R. Del Rio, M. Phillippe, C. Teuscher, and E. A. Bonney, “Resistance to lipopolysaccharide-induced preterm delivery mediated by regulatory T cell function in mice,” Biology of Reproduction, vol. 80, no. 5, pp. 874–881, 2009. [36] A. S. Tait, C. L. Butts, and E. M. Sternberg, “The role of glucocorticoids and progestins in inﬂammatory, autoimmune, and infectious disease,” Journal of Leukocyte Biology, vol. 84, no. 4, pp. 924–931, 2008. [37] A. E. Schindler, “Immunology and progestins in pregnancy,” Gynecological Endocrinology, vol. 13, no. 4, pp. 47–50, 1999. [38] S. E. Segerer, N. M u¨ller, J. van den Brandt et al., “Impact of female sex hormones on the maturation and function of human dendritic cells,” American Journal of Reproductive Immunology, vol. 62, no. 3, pp. 165–173, 2009. [39] J. P. Lydon, F. J. De Mayo, C. R. Funk et al., “Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities,” Genes and Development, vol. 9, no. 18, pp. 2266–2278, 1995. [40] M.-J. Oh and B. A. Croy, “A map of relationships between uterine natural killer cells and progesterone receptor express- ing cells during mouse pregnancy,” Placenta, vol. 29, no. 4, pp. 317–323, 2008. [41] S. Parry, J. Holder, and J. F. Strauss III, “Mechanisms of trophoblast-virus interaction,” Journal of Reproductive Immunology, vol. 37, no. 1, pp. 25–34, 1997. [42] H. Koi, J. Zhang, A. Makrigiannakis et al., “Diﬀerential expression of the coxsackievirus and adenovirus receptor regulates adenovirus infection of the placenta,” Biology of Reproduction, vol. 64, no. 3, pp. 1001–1009, 2001. [43] F. Arechavaleta-Velasco, H. Koi, J. F. Strauss III, and S. Parry, “Viral infection of the trophoblast: time to take a serious look at its role in abnormal implantation and placentation?” Journal of Reproductive Immunology, vol. 55, no. 1-2, pp. 113– 121, 2002. [44] L. F. Gonc¸alves, T. Chaiworapongsa, and R. Romero, “Intrauterine infection and prematurity,” Mental Retardation and Developmental Disabilities Research Reviews, vol. 8, no. 1, pp. 3–13, 2002. [45] K. D. Wenstrom, W. W. Andrews, N. E. Bowles, J. A. Towbin, J. C. Hauth, and R. L. Goldenberg, “Intrauterine viral infection at the time of second trimester genetic amniocentesis,” Obstetrics and Gynecology, vol. 92, no. 3, pp. 420–424, 1998. [46] E. Hirsch and H. Wang, “The molecular pathophysiology of bacterially induced preterm labor: insights from the murine model,” Journal of the Society for Gynecologic Investigation, vol. 12, no. 3, pp. 145–155, 2005. [47] S. L. Hillier, “The complexity of microbial diversity in bacterial vaginosis,” The New England Journal of Medicine, vol. 353, no. 18, pp. 1886–1887, 2005. [48] M. S. Esplin, R. Romero, T. Chaiworapongsa et al., “Monocyte chemotactic protein-1 is increased in the amniotic ﬂuid of women who deliver preterm in the presence or absence of intra-amniotic infection,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 17, no. 6, pp. 365–373, 2005. [49] P. Mittal, R. Romero, J. P. Kusanovic et al., “CXCL6 (granu- locyte chemotactic protein-2): a novel chemokine involved in